Category Specific RSS

Cynata Therapeutics

Cynata recruits first patient for Phase 2 trial of stem cells for graft vs host disease

Aussie clinical stage biotech company Cynata Therapeutics (ASX: CYP) has marked a milestone in its Phase 2 clinical trial of…

1 year ago

Cynata to tackle common transplant side effect with lead drug CYP-001

The first successful organ donation occurred in 1954 where a living donor gave a kidney to his identical twin. Since…

3 years ago